A 2019 study highlighted that many vitamins and supplements remain usable for years past their expiration dates, although this is not a blanket rule for all formulations
Transglutaminase 2 expression predicts progression free survival in non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
AOD 9604 has a substantial history of clinical study
Experimental chronic models assessing only one terminal endpoint may not show effects, hence questioning the exposure period required to observe effects
Additionally, BPC 157 administration counteracted various free radicalinduced lesions and increased free radical formation in other organs (Sikiric et al., 1993